Global Liposome Drug Delivery Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
Summary
Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only. In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.
According to APO Research, The global Liposome Drug Delivery market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Liposome Drug Delivery is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Liposome Drug Delivery is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Liposome Drug Delivery is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Liposome Drug Delivery is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Liposome Drug Delivery include Gilead Sciences, Pacira, Sun Pharmaceutical, Johnson & Johnson, Luye Pharma, Sigma-Tau, Ipsen (Onivyde), CSPC and Teva Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Liposome Drug Delivery, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Liposome Drug Delivery, also provides the sales of main regions and countries. Of the upcoming market potential for Liposome Drug Delivery, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Liposome Drug Delivery sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Liposome Drug Delivery market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Liposome Drug Delivery sales, projected growth trends, production technology, application and end-user industry.
Liposome Drug Delivery segment by Company
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liposome Drug Delivery market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Liposome Drug Delivery and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liposome Drug Delivery.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Liposome Drug Delivery market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Liposome Drug Delivery manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Liposome Drug Delivery in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Liposome Drug Delivery in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only. In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.
According to APO Research, The global Liposome Drug Delivery market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Liposome Drug Delivery is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Liposome Drug Delivery is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Liposome Drug Delivery is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Liposome Drug Delivery is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Liposome Drug Delivery include Gilead Sciences, Pacira, Sun Pharmaceutical, Johnson & Johnson, Luye Pharma, Sigma-Tau, Ipsen (Onivyde), CSPC and Teva Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Liposome Drug Delivery, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Liposome Drug Delivery, also provides the sales of main regions and countries. Of the upcoming market potential for Liposome Drug Delivery, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Liposome Drug Delivery sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Liposome Drug Delivery market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Liposome Drug Delivery sales, projected growth trends, production technology, application and end-user industry.
Liposome Drug Delivery segment by Company
- Gilead Sciences
- Pacira
- Sun Pharmaceutical
- Johnson & Johnson
- Luye Pharma
- Sigma-Tau
- Ipsen (Onivyde)
- CSPC
- Teva Pharmaceutical
- Novartis
- Fudan-Zhangjiang
- Liposomal Doxorubicin
- Liposomal Amphoteracin B
- Liposomal Paclitaxel
- Others
- Fungal Infection Therapy
- Cancer & Tumor Therapy
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liposome Drug Delivery market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Liposome Drug Delivery and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liposome Drug Delivery.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Liposome Drug Delivery market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Liposome Drug Delivery manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Liposome Drug Delivery in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Liposome Drug Delivery in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Liposome Drug Delivery Market Size, 2019 VS 2023 VS 2030
1.3 Global Liposome Drug Delivery Market Size Estimates and Forecasts (2019-2030)
1.4 Global Liposome Drug Delivery Sales Estimates and Forecasts (2019-2030)
1.5 Global Liposome Drug Delivery Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 GLOBAL LIPOSOME DRUG DELIVERY MARKET DYNAMICS
2.1 Liposome Drug Delivery Industry Trends
2.2 Liposome Drug Delivery Industry Drivers
2.3 Liposome Drug Delivery Industry Opportunities and Challenges
2.4 Liposome Drug Delivery Industry Restraints
3 LIPOSOME DRUG DELIVERY MARKET BY MANUFACTURERS
3.1 Global Liposome Drug Delivery Revenue by Manufacturers (2019-2024)
3.2 Global Liposome Drug Delivery Sales by Manufacturers (2019-2024)
3.3 Global Liposome Drug Delivery Average Sales Price by Manufacturers (2019-2024)
3.4 Global Liposome Drug Delivery Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Liposome Drug Delivery Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Liposome Drug Delivery Manufacturers, Product Type & Application
3.7 Global Liposome Drug Delivery Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Liposome Drug Delivery Market CR5 and HHI
3.8.2 Global Top 5 and 10 Liposome Drug Delivery Players Market Share by Revenue in 2023
3.8.3 2023 Liposome Drug Delivery Tier 1, Tier 2, and Tier
4 LIPOSOME DRUG DELIVERY MARKET BY TYPE
4.1 Liposome Drug Delivery Type Introduction
4.1.1 Liposomal Doxorubicin
4.1.2 Liposomal Amphoteracin B
4.1.3 Liposomal Paclitaxel
4.1.4 Others
4.2 Global Liposome Drug Delivery Sales by Type
4.2.1 Global Liposome Drug Delivery Sales by Type (2019 VS 2023 VS 2030)
4.2.2 Global Liposome Drug Delivery Sales by Type (2019-2030)
4.2.3 Global Liposome Drug Delivery Sales Market Share by Type (2019-2030)
4.3 Global Liposome Drug Delivery Revenue by Type
4.3.1 Global Liposome Drug Delivery Revenue by Type (2019 VS 2023 VS 2030)
4.3.2 Global Liposome Drug Delivery Revenue by Type (2019-2030)
4.3.3 Global Liposome Drug Delivery Revenue Market Share by Type (2019-2030)
5 LIPOSOME DRUG DELIVERY MARKET BY APPLICATION
5.1 Liposome Drug Delivery Application Introduction
5.1.1 Fungal Infection Therapy
5.1.2 Cancer & Tumor Therapy
5.1.3 Others
5.2 Global Liposome Drug Delivery Sales by Application
5.2.1 Global Liposome Drug Delivery Sales by Application (2019 VS 2023 VS 2030)
5.2.2 Global Liposome Drug Delivery Sales by Application (2019-2030)
5.2.3 Global Liposome Drug Delivery Sales Market Share by Application (2019-2030)
5.3 Global Liposome Drug Delivery Revenue by Application
5.3.1 Global Liposome Drug Delivery Revenue by Application (2019 VS 2023 VS 2030)
5.3.2 Global Liposome Drug Delivery Revenue by Application (2019-2030)
5.3.3 Global Liposome Drug Delivery Revenue Market Share by Application (2019-2030)
6 GLOBAL LIPOSOME DRUG DELIVERY SALES BY REGION
6.1 Global Liposome Drug Delivery Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Liposome Drug Delivery Sales by Region (2019-2030)
6.2.1 Global Liposome Drug Delivery Sales by Region (2019-2024)
6.2.2 Global Liposome Drug Delivery Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Liposome Drug Delivery Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Liposome Drug Delivery Sales by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Liposome Drug Delivery Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Liposome Drug Delivery Sales by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Liposome Drug Delivery Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Liposome Drug Delivery Sales by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 LAMEA
6.6.1 LAMEA Liposome Drug Delivery Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 LAMEA Liposome Drug Delivery Sales by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.6 GCC Countries
7 GLOBAL LIPOSOME DRUG DELIVERY REVENUE BY REGION
7.1 Global Liposome Drug Delivery Revenue by Region
7.1.1 Global Liposome Drug Delivery Revenue by Region: 2019 VS 2023 VS 2030
7.1.2 Global Liposome Drug Delivery Revenue by Region (2019-2024)
7.1.3 Global Liposome Drug Delivery Revenue by Region (2025-2030)
7.1.4 Global Liposome Drug Delivery Revenue Market Share by Region (2019-2030)
7.2 North America
7.2.1 North America Liposome Drug Delivery Revenue (2019-2030)
7.2.2 North America Liposome Drug Delivery Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
7.3.1 Europe Liposome Drug Delivery Revenue (2019-2030)
7.3.2 Europe Liposome Drug Delivery Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
7.4.1 Asia-Pacific Liposome Drug Delivery Revenue (2019-2030)
7.4.2 Asia-Pacific Liposome Drug Delivery Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
7.5.1 LAMEA Liposome Drug Delivery Revenue (2019-2030)
7.5.2 LAMEA Liposome Drug Delivery Revenue Share by Country: 2019 VS 2023 VS 2030
8 COMPANY PROFILES
8.1 Gilead Sciences
8.1.1 Gilead Sciences Comapny Information
8.1.2 Gilead Sciences Business Overview
8.1.3 Gilead Sciences Liposome Drug Delivery Sales, Price, Revenue and Gross Margin (2019-2024)
8.1.4 Gilead Sciences Liposome Drug Delivery Product Portfolio
8.1.5 Gilead Sciences Recent Developments
8.2 Pacira
8.2.1 Pacira Comapny Information
8.2.2 Pacira Business Overview
8.2.3 Pacira Liposome Drug Delivery Sales, Price, Revenue and Gross Margin (2019-2024)
8.2.4 Pacira Liposome Drug Delivery Product Portfolio
8.2.5 Pacira Recent Developments
8.3 Sun Pharmaceutical
8.3.1 Sun Pharmaceutical Comapny Information
8.3.2 Sun Pharmaceutical Business Overview
8.3.3 Sun Pharmaceutical Liposome Drug Delivery Sales, Price, Revenue and Gross Margin (2019-2024)
8.3.4 Sun Pharmaceutical Liposome Drug Delivery Product Portfolio
8.3.5 Sun Pharmaceutical Recent Developments
8.4 Johnson & Johnson
8.4.1 Johnson & Johnson Comapny Information
8.4.2 Johnson & Johnson Business Overview
8.4.3 Johnson & Johnson Liposome Drug Delivery Sales, Price, Revenue and Gross Margin (2019-2024)
8.4.4 Johnson & Johnson Liposome Drug Delivery Product Portfolio
8.4.5 Johnson & Johnson Recent Developments
8.5 Luye Pharma
8.5.1 Luye Pharma Comapny Information
8.5.2 Luye Pharma Business Overview
8.5.3 Luye Pharma Liposome Drug Delivery Sales, Price, Revenue and Gross Margin (2019-2024)
8.5.4 Luye Pharma Liposome Drug Delivery Product Portfolio
8.5.5 Luye Pharma Recent Developments
8.6 Sigma-Tau
8.6.1 Sigma-Tau Comapny Information
8.6.2 Sigma-Tau Business Overview
8.6.3 Sigma-Tau Liposome Drug Delivery Sales, Price, Revenue and Gross Margin (2019-2024)
8.6.4 Sigma-Tau Liposome Drug Delivery Product Portfolio
8.6.5 Sigma-Tau Recent Developments
8.7 Ipsen (Onivyde)
8.7.1 Ipsen (Onivyde) Comapny Information
8.7.2 Ipsen (Onivyde) Business Overview
8.7.3 Ipsen (Onivyde) Liposome Drug Delivery Sales, Price, Revenue and Gross Margin (2019-2024)
8.7.4 Ipsen (Onivyde) Liposome Drug Delivery Product Portfolio
8.7.5 Ipsen (Onivyde) Recent Developments
8.8 CSPC
8.8.1 CSPC Comapny Information
8.8.2 CSPC Business Overview
8.8.3 CSPC Liposome Drug Delivery Sales, Price, Revenue and Gross Margin (2019-2024)
8.8.4 CSPC Liposome Drug Delivery Product Portfolio
8.8.5 CSPC Recent Developments
8.9 Teva Pharmaceutical
8.9.1 Teva Pharmaceutical Comapny Information
8.9.2 Teva Pharmaceutical Business Overview
8.9.3 Teva Pharmaceutical Liposome Drug Delivery Sales, Price, Revenue and Gross Margin (2019-2024)
8.9.4 Teva Pharmaceutical Liposome Drug Delivery Product Portfolio
8.9.5 Teva Pharmaceutical Recent Developments
8.10 Novartis
8.10.1 Novartis Comapny Information
8.10.2 Novartis Business Overview
8.10.3 Novartis Liposome Drug Delivery Sales, Price, Revenue and Gross Margin (2019-2024)
8.10.4 Novartis Liposome Drug Delivery Product Portfolio
8.10.5 Novartis Recent Developments
8.11 Fudan-Zhangjiang
8.11.1 Fudan-Zhangjiang Comapny Information
8.11.2 Fudan-Zhangjiang Business Overview
8.11.3 Fudan-Zhangjiang Liposome Drug Delivery Sales, Price, Revenue and Gross Margin (2019-2024)
8.11.4 Fudan-Zhangjiang Liposome Drug Delivery Product Portfolio
8.11.5 Fudan-Zhangjiang Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Liposome Drug Delivery Value Chain Analysis
9.1.1 Liposome Drug Delivery Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Liposome Drug Delivery Production Mode & Process
9.2 Liposome Drug Delivery Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Liposome Drug Delivery Distributors
9.2.3 Liposome Drug Delivery Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
1.1 Product Definition
1.2 Global Liposome Drug Delivery Market Size, 2019 VS 2023 VS 2030
1.3 Global Liposome Drug Delivery Market Size Estimates and Forecasts (2019-2030)
1.4 Global Liposome Drug Delivery Sales Estimates and Forecasts (2019-2030)
1.5 Global Liposome Drug Delivery Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 GLOBAL LIPOSOME DRUG DELIVERY MARKET DYNAMICS
2.1 Liposome Drug Delivery Industry Trends
2.2 Liposome Drug Delivery Industry Drivers
2.3 Liposome Drug Delivery Industry Opportunities and Challenges
2.4 Liposome Drug Delivery Industry Restraints
3 LIPOSOME DRUG DELIVERY MARKET BY MANUFACTURERS
3.1 Global Liposome Drug Delivery Revenue by Manufacturers (2019-2024)
3.2 Global Liposome Drug Delivery Sales by Manufacturers (2019-2024)
3.3 Global Liposome Drug Delivery Average Sales Price by Manufacturers (2019-2024)
3.4 Global Liposome Drug Delivery Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Liposome Drug Delivery Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Liposome Drug Delivery Manufacturers, Product Type & Application
3.7 Global Liposome Drug Delivery Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Liposome Drug Delivery Market CR5 and HHI
3.8.2 Global Top 5 and 10 Liposome Drug Delivery Players Market Share by Revenue in 2023
3.8.3 2023 Liposome Drug Delivery Tier 1, Tier 2, and Tier
4 LIPOSOME DRUG DELIVERY MARKET BY TYPE
4.1 Liposome Drug Delivery Type Introduction
4.1.1 Liposomal Doxorubicin
4.1.2 Liposomal Amphoteracin B
4.1.3 Liposomal Paclitaxel
4.1.4 Others
4.2 Global Liposome Drug Delivery Sales by Type
4.2.1 Global Liposome Drug Delivery Sales by Type (2019 VS 2023 VS 2030)
4.2.2 Global Liposome Drug Delivery Sales by Type (2019-2030)
4.2.3 Global Liposome Drug Delivery Sales Market Share by Type (2019-2030)
4.3 Global Liposome Drug Delivery Revenue by Type
4.3.1 Global Liposome Drug Delivery Revenue by Type (2019 VS 2023 VS 2030)
4.3.2 Global Liposome Drug Delivery Revenue by Type (2019-2030)
4.3.3 Global Liposome Drug Delivery Revenue Market Share by Type (2019-2030)
5 LIPOSOME DRUG DELIVERY MARKET BY APPLICATION
5.1 Liposome Drug Delivery Application Introduction
5.1.1 Fungal Infection Therapy
5.1.2 Cancer & Tumor Therapy
5.1.3 Others
5.2 Global Liposome Drug Delivery Sales by Application
5.2.1 Global Liposome Drug Delivery Sales by Application (2019 VS 2023 VS 2030)
5.2.2 Global Liposome Drug Delivery Sales by Application (2019-2030)
5.2.3 Global Liposome Drug Delivery Sales Market Share by Application (2019-2030)
5.3 Global Liposome Drug Delivery Revenue by Application
5.3.1 Global Liposome Drug Delivery Revenue by Application (2019 VS 2023 VS 2030)
5.3.2 Global Liposome Drug Delivery Revenue by Application (2019-2030)
5.3.3 Global Liposome Drug Delivery Revenue Market Share by Application (2019-2030)
6 GLOBAL LIPOSOME DRUG DELIVERY SALES BY REGION
6.1 Global Liposome Drug Delivery Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Liposome Drug Delivery Sales by Region (2019-2030)
6.2.1 Global Liposome Drug Delivery Sales by Region (2019-2024)
6.2.2 Global Liposome Drug Delivery Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Liposome Drug Delivery Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Liposome Drug Delivery Sales by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Liposome Drug Delivery Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Liposome Drug Delivery Sales by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Liposome Drug Delivery Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Liposome Drug Delivery Sales by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 LAMEA
6.6.1 LAMEA Liposome Drug Delivery Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 LAMEA Liposome Drug Delivery Sales by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.6 GCC Countries
7 GLOBAL LIPOSOME DRUG DELIVERY REVENUE BY REGION
7.1 Global Liposome Drug Delivery Revenue by Region
7.1.1 Global Liposome Drug Delivery Revenue by Region: 2019 VS 2023 VS 2030
7.1.2 Global Liposome Drug Delivery Revenue by Region (2019-2024)
7.1.3 Global Liposome Drug Delivery Revenue by Region (2025-2030)
7.1.4 Global Liposome Drug Delivery Revenue Market Share by Region (2019-2030)
7.2 North America
7.2.1 North America Liposome Drug Delivery Revenue (2019-2030)
7.2.2 North America Liposome Drug Delivery Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
7.3.1 Europe Liposome Drug Delivery Revenue (2019-2030)
7.3.2 Europe Liposome Drug Delivery Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
7.4.1 Asia-Pacific Liposome Drug Delivery Revenue (2019-2030)
7.4.2 Asia-Pacific Liposome Drug Delivery Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
7.5.1 LAMEA Liposome Drug Delivery Revenue (2019-2030)
7.5.2 LAMEA Liposome Drug Delivery Revenue Share by Country: 2019 VS 2023 VS 2030
8 COMPANY PROFILES
8.1 Gilead Sciences
8.1.1 Gilead Sciences Comapny Information
8.1.2 Gilead Sciences Business Overview
8.1.3 Gilead Sciences Liposome Drug Delivery Sales, Price, Revenue and Gross Margin (2019-2024)
8.1.4 Gilead Sciences Liposome Drug Delivery Product Portfolio
8.1.5 Gilead Sciences Recent Developments
8.2 Pacira
8.2.1 Pacira Comapny Information
8.2.2 Pacira Business Overview
8.2.3 Pacira Liposome Drug Delivery Sales, Price, Revenue and Gross Margin (2019-2024)
8.2.4 Pacira Liposome Drug Delivery Product Portfolio
8.2.5 Pacira Recent Developments
8.3 Sun Pharmaceutical
8.3.1 Sun Pharmaceutical Comapny Information
8.3.2 Sun Pharmaceutical Business Overview
8.3.3 Sun Pharmaceutical Liposome Drug Delivery Sales, Price, Revenue and Gross Margin (2019-2024)
8.3.4 Sun Pharmaceutical Liposome Drug Delivery Product Portfolio
8.3.5 Sun Pharmaceutical Recent Developments
8.4 Johnson & Johnson
8.4.1 Johnson & Johnson Comapny Information
8.4.2 Johnson & Johnson Business Overview
8.4.3 Johnson & Johnson Liposome Drug Delivery Sales, Price, Revenue and Gross Margin (2019-2024)
8.4.4 Johnson & Johnson Liposome Drug Delivery Product Portfolio
8.4.5 Johnson & Johnson Recent Developments
8.5 Luye Pharma
8.5.1 Luye Pharma Comapny Information
8.5.2 Luye Pharma Business Overview
8.5.3 Luye Pharma Liposome Drug Delivery Sales, Price, Revenue and Gross Margin (2019-2024)
8.5.4 Luye Pharma Liposome Drug Delivery Product Portfolio
8.5.5 Luye Pharma Recent Developments
8.6 Sigma-Tau
8.6.1 Sigma-Tau Comapny Information
8.6.2 Sigma-Tau Business Overview
8.6.3 Sigma-Tau Liposome Drug Delivery Sales, Price, Revenue and Gross Margin (2019-2024)
8.6.4 Sigma-Tau Liposome Drug Delivery Product Portfolio
8.6.5 Sigma-Tau Recent Developments
8.7 Ipsen (Onivyde)
8.7.1 Ipsen (Onivyde) Comapny Information
8.7.2 Ipsen (Onivyde) Business Overview
8.7.3 Ipsen (Onivyde) Liposome Drug Delivery Sales, Price, Revenue and Gross Margin (2019-2024)
8.7.4 Ipsen (Onivyde) Liposome Drug Delivery Product Portfolio
8.7.5 Ipsen (Onivyde) Recent Developments
8.8 CSPC
8.8.1 CSPC Comapny Information
8.8.2 CSPC Business Overview
8.8.3 CSPC Liposome Drug Delivery Sales, Price, Revenue and Gross Margin (2019-2024)
8.8.4 CSPC Liposome Drug Delivery Product Portfolio
8.8.5 CSPC Recent Developments
8.9 Teva Pharmaceutical
8.9.1 Teva Pharmaceutical Comapny Information
8.9.2 Teva Pharmaceutical Business Overview
8.9.3 Teva Pharmaceutical Liposome Drug Delivery Sales, Price, Revenue and Gross Margin (2019-2024)
8.9.4 Teva Pharmaceutical Liposome Drug Delivery Product Portfolio
8.9.5 Teva Pharmaceutical Recent Developments
8.10 Novartis
8.10.1 Novartis Comapny Information
8.10.2 Novartis Business Overview
8.10.3 Novartis Liposome Drug Delivery Sales, Price, Revenue and Gross Margin (2019-2024)
8.10.4 Novartis Liposome Drug Delivery Product Portfolio
8.10.5 Novartis Recent Developments
8.11 Fudan-Zhangjiang
8.11.1 Fudan-Zhangjiang Comapny Information
8.11.2 Fudan-Zhangjiang Business Overview
8.11.3 Fudan-Zhangjiang Liposome Drug Delivery Sales, Price, Revenue and Gross Margin (2019-2024)
8.11.4 Fudan-Zhangjiang Liposome Drug Delivery Product Portfolio
8.11.5 Fudan-Zhangjiang Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Liposome Drug Delivery Value Chain Analysis
9.1.1 Liposome Drug Delivery Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Liposome Drug Delivery Production Mode & Process
9.2 Liposome Drug Delivery Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Liposome Drug Delivery Distributors
9.2.3 Liposome Drug Delivery Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
LIST OF TABLES
Table 1. Liposome Drug Delivery Industry Trends
Table 2. Liposome Drug Delivery Industry Drivers
Table 3. Liposome Drug Delivery Industry Opportunities and Challenges
Table 4. Liposome Drug Delivery Industry Restraints
Table 5. Global Liposome Drug Delivery Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 6. Global Liposome Drug Delivery Revenue Market Share by Manufacturers (2019-2024)
Table 7. Global Liposome Drug Delivery Sales by Manufacturers (K Vial) & (2019-2024)
Table 8. Global Liposome Drug Delivery Sales Market Share by Manufacturers
Table 9. Global Liposome Drug Delivery Average Sales Price (USD/Vial) of Manufacturers (2019-2024)
Table 10. Global Liposome Drug Delivery Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 11. Global Liposome Drug Delivery Key Manufacturers Manufacturing Sites & Headquarters
Table 12. Global Liposome Drug Delivery Manufacturers, Product Type & Application
Table 13. Global Liposome Drug Delivery Manufacturers Commercialization Time
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Liposome Drug Delivery by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 16. Major Manufacturers of Liposomal Doxorubicin
Table 17. Major Manufacturers of Liposomal Amphoteracin B
Table 18. Major Manufacturers of Liposomal Paclitaxel
Table 19. Major Manufacturers of Others
Table 20. Global Liposome Drug Delivery Sales by Type 2019 VS 2023 VS 2030 (K Vial)
Table 21. Global Liposome Drug Delivery Sales by Type (2019-2024) & (K Vial)
Table 22. Global Liposome Drug Delivery Sales by Type (2025-2030) & (K Vial)
Table 23. Global Liposome Drug Delivery Sales Market Share by Type (2019-2024)
Table 24. Global Liposome Drug Delivery Sales Market Share by Type (2025-2030)
Table 25. Global Liposome Drug Delivery Revenue by Type 2019 VS 2023 VS 2030 (K Vial)
Table 26. Global Liposome Drug Delivery Revenue by Type (2019-2024) & (K Vial)
Table 27. Global Liposome Drug Delivery Revenue by Type (2025-2030) & (K Vial)
Table 28. Global Liposome Drug Delivery Revenue Market Share by Type (2019-2024)
Table 29. Global Liposome Drug Delivery Revenue Market Share by Type (2025-2030)
Table 30. Major Manufacturers of Fungal Infection Therapy
Table 31. Major Manufacturers of Cancer & Tumor Therapy
Table 32. Major Manufacturers of Others
Table 33. Global Liposome Drug Delivery Sales by Application 2019 VS 2023 VS 2030 (K Vial)
Table 34. Global Liposome Drug Delivery Sales by Application (2019-2024) & (K Vial)
Table 35. Global Liposome Drug Delivery Sales by Application (2025-2030) & (K Vial)
Table 36. Global Liposome Drug Delivery Sales Market Share by Application (2019-2024)
Table 37. Global Liposome Drug Delivery Sales Market Share by Application (2025-2030)
Table 38. Global Liposome Drug Delivery Revenue by Application 2019 VS 2023 VS 2030 (K Vial)
Table 39. Global Liposome Drug Delivery Revenue by Application (2019-2024) & (K Vial)
Table 40. Global Liposome Drug Delivery Revenue by Application (2025-2030) & (K Vial)
Table 41. Global Liposome Drug Delivery Revenue Market Share by Application (2019-2024)
Table 42. Global Liposome Drug Delivery Revenue Market Share by Application (2025-2030)
Table 43. Global Liposome Drug Delivery Sales by Region: 2019 VS 2023 VS 2030 (K Vial)
Table 44. Global Liposome Drug Delivery Sales by Region (2019-2024) & (K Vial)
Table 45. Global Liposome Drug Delivery Sales Market Share by Region (2019-2024)
Table 46. Global Liposome Drug Delivery Sales Forecasted by Region (2025-2030) & (K Vial)
Table 47. Global Liposome Drug Delivery Sales Forecasted Market Share by Region (2025-2030)
Table 48. North America Liposome Drug Delivery Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (K Vial)
Table 49. North America Liposome Drug Delivery Sales by Country (2019-2024) & (K Vial)
Table 50. North America Liposome Drug Delivery Sales by Country (2025-2030) & (K Vial)
Table 51. Europe Liposome Drug Delivery Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (K Vial)
Table 52. Europe Liposome Drug Delivery Sales by Country (2019-2024) & (K Vial)
Table 53. Europe Liposome Drug Delivery Sales by Country (2025-2030) & (K Vial)
Table 54. Asia Pacific Liposome Drug Delivery Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (K Vial)
Table 55. Asia Pacific Liposome Drug Delivery Sales by Country (2019-2024) & (K Vial)
Table 56. Asia Pacific Liposome Drug Delivery Sales by Country (2025-2030) & (K Vial)
Table 57. LAMEA Liposome Drug Delivery Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (K Vial)
Table 58. LAMEA Liposome Drug Delivery Sales by Country (2019-2024) & (K Vial)
Table 59. LAMEA Liposome Drug Delivery Sales by Country (2025-2030) & (K Vial)
Table 60. Global Liposome Drug Delivery Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 61. Global Liposome Drug Delivery Revenue by Region (2019-2024) & (US$ Million)
Table 62. Global Liposome Drug Delivery Revenue by Region (2025-2030) & (US$ Million)
Table 63. Global Liposome Drug Delivery Revenue Market Share by Region (2019-2024)
Table 64. Global Liposome Drug Delivery Revenue Market Share by Region (2025-2030)
Table 65. Gilead Sciences Company Information
Table 66. Gilead Sciences Business Overview
Table 67. Gilead Sciences Liposome Drug Delivery Sales (K Vial), Price (USD/Vial), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 68. Gilead Sciences Liposome Drug Delivery Product Portfolio
Table 69. Gilead Sciences Recent Development
Table 70. Pacira Company Information
Table 71. Pacira Business Overview
Table 72. Pacira Liposome Drug Delivery Sales (K Vial), Price (USD/Vial), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 73. Pacira Liposome Drug Delivery Product Portfolio
Table 74. Pacira Recent Development
Table 75. Sun Pharmaceutical Company Information
Table 76. Sun Pharmaceutical Business Overview
Table 77. Sun Pharmaceutical Liposome Drug Delivery Sales (K Vial), Price (USD/Vial), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 78. Sun Pharmaceutical Liposome Drug Delivery Product Portfolio
Table 79. Sun Pharmaceutical Recent Development
Table 80. Johnson & Johnson Company Information
Table 81. Johnson & Johnson Business Overview
Table 82. Johnson & Johnson Liposome Drug Delivery Sales (K Vial), Price (USD/Vial), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 83. Johnson & Johnson Liposome Drug Delivery Product Portfolio
Table 84. Johnson & Johnson Recent Development
Table 85. Luye Pharma Company Information
Table 86. Luye Pharma Business Overview
Table 87. Luye Pharma Liposome Drug Delivery Sales (K Vial), Price (USD/Vial), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 88. Luye Pharma Liposome Drug Delivery Product Portfolio
Table 89. Luye Pharma Recent Development
Table 90. Sigma-Tau Company Information
Table 91. Sigma-Tau Business Overview
Table 92. Sigma-Tau Liposome Drug Delivery Sales (K Vial), Price (USD/Vial), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 93. Sigma-Tau Liposome Drug Delivery Product Portfolio
Table 94. Sigma-Tau Recent Development
Table 95. Ipsen (Onivyde) Company Information
Table 96. Ipsen (Onivyde) Business Overview
Table 97. Ipsen (Onivyde) Liposome Drug Delivery Sales (K Vial), Price (USD/Vial), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 98. Ipsen (Onivyde) Liposome Drug Delivery Product Portfolio
Table 99. Ipsen (Onivyde) Recent Development
Table 100. CSPC Company Information
Table 101. CSPC Business Overview
Table 102. CSPC Liposome Drug Delivery Sales (K Vial), Price (USD/Vial), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 103. CSPC Liposome Drug Delivery Product Portfolio
Table 104. CSPC Recent Development
Table 105. Teva Pharmaceutical Company Information
Table 106. Teva Pharmaceutical Business Overview
Table 107. Teva Pharmaceutical Liposome Drug Delivery Sales (K Vial), Price (USD/Vial), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 108. Teva Pharmaceutical Liposome Drug Delivery Product Portfolio
Table 109. Teva Pharmaceutical Recent Development
Table 110. Novartis Company Information
Table 111. Novartis Business Overview
Table 112. Novartis Liposome Drug Delivery Sales (K Vial), Price (USD/Vial), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 113. Novartis Liposome Drug Delivery Product Portfolio
Table 114. Novartis Recent Development
Table 115. Fudan-Zhangjiang Company Information
Table 116. Fudan-Zhangjiang Business Overview
Table 117. Fudan-Zhangjiang Liposome Drug Delivery Sales (K Vial), Price (USD/Vial), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 118. Fudan-Zhangjiang Liposome Drug Delivery Product Portfolio
Table 119. Fudan-Zhangjiang Recent Development
Table 120. Key Raw Materials
Table 121. Raw Materials Key Suppliers
Table 122. Liposome Drug Delivery Distributors List
Table 123. Liposome Drug Delivery Customers List
Table 124. Research Programs/Design for This Report
Table 125. Authors List of This Report
Table 126. Secondary Sources
Table 127. Primary Sources
Table 1. Liposome Drug Delivery Industry Trends
Table 2. Liposome Drug Delivery Industry Drivers
Table 3. Liposome Drug Delivery Industry Opportunities and Challenges
Table 4. Liposome Drug Delivery Industry Restraints
Table 5. Global Liposome Drug Delivery Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 6. Global Liposome Drug Delivery Revenue Market Share by Manufacturers (2019-2024)
Table 7. Global Liposome Drug Delivery Sales by Manufacturers (K Vial) & (2019-2024)
Table 8. Global Liposome Drug Delivery Sales Market Share by Manufacturers
Table 9. Global Liposome Drug Delivery Average Sales Price (USD/Vial) of Manufacturers (2019-2024)
Table 10. Global Liposome Drug Delivery Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 11. Global Liposome Drug Delivery Key Manufacturers Manufacturing Sites & Headquarters
Table 12. Global Liposome Drug Delivery Manufacturers, Product Type & Application
Table 13. Global Liposome Drug Delivery Manufacturers Commercialization Time
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Liposome Drug Delivery by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 16. Major Manufacturers of Liposomal Doxorubicin
Table 17. Major Manufacturers of Liposomal Amphoteracin B
Table 18. Major Manufacturers of Liposomal Paclitaxel
Table 19. Major Manufacturers of Others
Table 20. Global Liposome Drug Delivery Sales by Type 2019 VS 2023 VS 2030 (K Vial)
Table 21. Global Liposome Drug Delivery Sales by Type (2019-2024) & (K Vial)
Table 22. Global Liposome Drug Delivery Sales by Type (2025-2030) & (K Vial)
Table 23. Global Liposome Drug Delivery Sales Market Share by Type (2019-2024)
Table 24. Global Liposome Drug Delivery Sales Market Share by Type (2025-2030)
Table 25. Global Liposome Drug Delivery Revenue by Type 2019 VS 2023 VS 2030 (K Vial)
Table 26. Global Liposome Drug Delivery Revenue by Type (2019-2024) & (K Vial)
Table 27. Global Liposome Drug Delivery Revenue by Type (2025-2030) & (K Vial)
Table 28. Global Liposome Drug Delivery Revenue Market Share by Type (2019-2024)
Table 29. Global Liposome Drug Delivery Revenue Market Share by Type (2025-2030)
Table 30. Major Manufacturers of Fungal Infection Therapy
Table 31. Major Manufacturers of Cancer & Tumor Therapy
Table 32. Major Manufacturers of Others
Table 33. Global Liposome Drug Delivery Sales by Application 2019 VS 2023 VS 2030 (K Vial)
Table 34. Global Liposome Drug Delivery Sales by Application (2019-2024) & (K Vial)
Table 35. Global Liposome Drug Delivery Sales by Application (2025-2030) & (K Vial)
Table 36. Global Liposome Drug Delivery Sales Market Share by Application (2019-2024)
Table 37. Global Liposome Drug Delivery Sales Market Share by Application (2025-2030)
Table 38. Global Liposome Drug Delivery Revenue by Application 2019 VS 2023 VS 2030 (K Vial)
Table 39. Global Liposome Drug Delivery Revenue by Application (2019-2024) & (K Vial)
Table 40. Global Liposome Drug Delivery Revenue by Application (2025-2030) & (K Vial)
Table 41. Global Liposome Drug Delivery Revenue Market Share by Application (2019-2024)
Table 42. Global Liposome Drug Delivery Revenue Market Share by Application (2025-2030)
Table 43. Global Liposome Drug Delivery Sales by Region: 2019 VS 2023 VS 2030 (K Vial)
Table 44. Global Liposome Drug Delivery Sales by Region (2019-2024) & (K Vial)
Table 45. Global Liposome Drug Delivery Sales Market Share by Region (2019-2024)
Table 46. Global Liposome Drug Delivery Sales Forecasted by Region (2025-2030) & (K Vial)
Table 47. Global Liposome Drug Delivery Sales Forecasted Market Share by Region (2025-2030)
Table 48. North America Liposome Drug Delivery Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (K Vial)
Table 49. North America Liposome Drug Delivery Sales by Country (2019-2024) & (K Vial)
Table 50. North America Liposome Drug Delivery Sales by Country (2025-2030) & (K Vial)
Table 51. Europe Liposome Drug Delivery Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (K Vial)
Table 52. Europe Liposome Drug Delivery Sales by Country (2019-2024) & (K Vial)
Table 53. Europe Liposome Drug Delivery Sales by Country (2025-2030) & (K Vial)
Table 54. Asia Pacific Liposome Drug Delivery Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (K Vial)
Table 55. Asia Pacific Liposome Drug Delivery Sales by Country (2019-2024) & (K Vial)
Table 56. Asia Pacific Liposome Drug Delivery Sales by Country (2025-2030) & (K Vial)
Table 57. LAMEA Liposome Drug Delivery Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (K Vial)
Table 58. LAMEA Liposome Drug Delivery Sales by Country (2019-2024) & (K Vial)
Table 59. LAMEA Liposome Drug Delivery Sales by Country (2025-2030) & (K Vial)
Table 60. Global Liposome Drug Delivery Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 61. Global Liposome Drug Delivery Revenue by Region (2019-2024) & (US$ Million)
Table 62. Global Liposome Drug Delivery Revenue by Region (2025-2030) & (US$ Million)
Table 63. Global Liposome Drug Delivery Revenue Market Share by Region (2019-2024)
Table 64. Global Liposome Drug Delivery Revenue Market Share by Region (2025-2030)
Table 65. Gilead Sciences Company Information
Table 66. Gilead Sciences Business Overview
Table 67. Gilead Sciences Liposome Drug Delivery Sales (K Vial), Price (USD/Vial), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 68. Gilead Sciences Liposome Drug Delivery Product Portfolio
Table 69. Gilead Sciences Recent Development
Table 70. Pacira Company Information
Table 71. Pacira Business Overview
Table 72. Pacira Liposome Drug Delivery Sales (K Vial), Price (USD/Vial), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 73. Pacira Liposome Drug Delivery Product Portfolio
Table 74. Pacira Recent Development
Table 75. Sun Pharmaceutical Company Information
Table 76. Sun Pharmaceutical Business Overview
Table 77. Sun Pharmaceutical Liposome Drug Delivery Sales (K Vial), Price (USD/Vial), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 78. Sun Pharmaceutical Liposome Drug Delivery Product Portfolio
Table 79. Sun Pharmaceutical Recent Development
Table 80. Johnson & Johnson Company Information
Table 81. Johnson & Johnson Business Overview
Table 82. Johnson & Johnson Liposome Drug Delivery Sales (K Vial), Price (USD/Vial), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 83. Johnson & Johnson Liposome Drug Delivery Product Portfolio
Table 84. Johnson & Johnson Recent Development
Table 85. Luye Pharma Company Information
Table 86. Luye Pharma Business Overview
Table 87. Luye Pharma Liposome Drug Delivery Sales (K Vial), Price (USD/Vial), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 88. Luye Pharma Liposome Drug Delivery Product Portfolio
Table 89. Luye Pharma Recent Development
Table 90. Sigma-Tau Company Information
Table 91. Sigma-Tau Business Overview
Table 92. Sigma-Tau Liposome Drug Delivery Sales (K Vial), Price (USD/Vial), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 93. Sigma-Tau Liposome Drug Delivery Product Portfolio
Table 94. Sigma-Tau Recent Development
Table 95. Ipsen (Onivyde) Company Information
Table 96. Ipsen (Onivyde) Business Overview
Table 97. Ipsen (Onivyde) Liposome Drug Delivery Sales (K Vial), Price (USD/Vial), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 98. Ipsen (Onivyde) Liposome Drug Delivery Product Portfolio
Table 99. Ipsen (Onivyde) Recent Development
Table 100. CSPC Company Information
Table 101. CSPC Business Overview
Table 102. CSPC Liposome Drug Delivery Sales (K Vial), Price (USD/Vial), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 103. CSPC Liposome Drug Delivery Product Portfolio
Table 104. CSPC Recent Development
Table 105. Teva Pharmaceutical Company Information
Table 106. Teva Pharmaceutical Business Overview
Table 107. Teva Pharmaceutical Liposome Drug Delivery Sales (K Vial), Price (USD/Vial), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 108. Teva Pharmaceutical Liposome Drug Delivery Product Portfolio
Table 109. Teva Pharmaceutical Recent Development
Table 110. Novartis Company Information
Table 111. Novartis Business Overview
Table 112. Novartis Liposome Drug Delivery Sales (K Vial), Price (USD/Vial), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 113. Novartis Liposome Drug Delivery Product Portfolio
Table 114. Novartis Recent Development
Table 115. Fudan-Zhangjiang Company Information
Table 116. Fudan-Zhangjiang Business Overview
Table 117. Fudan-Zhangjiang Liposome Drug Delivery Sales (K Vial), Price (USD/Vial), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 118. Fudan-Zhangjiang Liposome Drug Delivery Product Portfolio
Table 119. Fudan-Zhangjiang Recent Development
Table 120. Key Raw Materials
Table 121. Raw Materials Key Suppliers
Table 122. Liposome Drug Delivery Distributors List
Table 123. Liposome Drug Delivery Customers List
Table 124. Research Programs/Design for This Report
Table 125. Authors List of This Report
Table 126. Secondary Sources
Table 127. Primary Sources
LIST OF FIGURES
Figure 1. Liposome Drug Delivery Product Picture
Figure 2. Global Liposome Drug Delivery Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Liposome Drug Delivery Market Size (2019-2030) & (US$ Million)
Figure 4. Global Liposome Drug Delivery Sales (2019-2030) & (K Vial)
Figure 5. Global Liposome Drug Delivery Average Price (USD/Vial) & (2019-2030)
Figure 6. Global Top 5 and 10 Liposome Drug Delivery Players Market Share by Revenue in 2023
Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Liposomal Doxorubicin Picture
Figure 9. Liposomal Amphoteracin B Picture
Figure 10. Liposomal Paclitaxel Picture
Figure 11. Others Picture
Figure 12. Global Liposome Drug Delivery Sales by Type (2019 VS 2023 VS 2030) & (K Vial)
Figure 13. Global Liposome Drug Delivery Sales Market Share 2019 VS 2023 VS 2030
Figure 14. Global Liposome Drug Delivery Sales Market Share by Type (2019-2030)
Figure 15. Global Liposome Drug Delivery Revenue by Type (2019 VS 2023 VS 2030) & (K Vial)
Figure 16. Global Liposome Drug Delivery Revenue Market Share 2019 VS 2023 VS 2030
Figure 17. Global Liposome Drug Delivery Revenue Market Share by Type (2019-2030)
Figure 18. Fungal Infection Therapy Picture
Figure 19. Cancer & Tumor Therapy Picture
Figure 20. Others Picture
Figure 21. Global Liposome Drug Delivery Sales by Application (2019 VS 2023 VS 2030) & (K Vial)
Figure 22. Global Liposome Drug Delivery Sales Market Share 2019 VS 2023 VS 2030
Figure 23. Global Liposome Drug Delivery Sales Market Share by Application (2019-2030)
Figure 24. Global Liposome Drug Delivery Revenue by Application (2019 VS 2023 VS 2030) & (K Vial)
Figure 25. Global Liposome Drug Delivery Revenue Market Share 2019 VS 2023 VS 2030
Figure 26. Global Liposome Drug Delivery Revenue Market Share by Application (2019-2030)
Figure 27. North America Liposome Drug Delivery Sales and Growth Rate (2019-2030) & (K Vial)
Figure 28. North America Liposome Drug Delivery Sales Market Share by Country (2019-2030)
Figure 29. U.S. Liposome Drug Delivery Sales and Growth Rate (2019-2030) & (K Vial)
Figure 30. Canada Liposome Drug Delivery Sales and Growth Rate (2019-2030) & (K Vial)
Figure 31. Europe Liposome Drug Delivery Sales and Growth Rate (2019-2030) & (K Vial)
Figure 32. Europe Liposome Drug Delivery Sales Market Share by Country (2019-2030)
Figure 33. Germany Liposome Drug Delivery Sales and Growth Rate (2019-2030) & (K Vial)
Figure 34. France Liposome Drug Delivery Sales and Growth Rate (2019-2030) & (K Vial)
Figure 35. U.K. Liposome Drug Delivery Sales and Growth Rate (2019-2030) & (K Vial)
Figure 36. Italy Liposome Drug Delivery Sales and Growth Rate (2019-2030) & (K Vial)
Figure 37. Netherlands Liposome Drug Delivery Sales and Growth Rate (2019-2030) & (K Vial)
Figure 38. Asia Pacific Liposome Drug Delivery Sales and Growth Rate (2019-2030) & (K Vial)
Figure 39. Asia Pacific Liposome Drug Delivery Sales Market Share by Country (2019-2030)
Figure 40. China Liposome Drug Delivery Sales and Growth Rate (2019-2030) & (K Vial)
Figure 41. Japan Liposome Drug Delivery Sales and Growth Rate (2019-2030) & (K Vial)
Figure 42. South Korea Liposome Drug Delivery Sales and Growth Rate (2019-2030) & (K Vial)
Figure 43. Southeast Asia Liposome Drug Delivery Sales and Growth Rate (2019-2030) & (K Vial)
Figure 44. India Liposome Drug Delivery Sales and Growth Rate (2019-2030) & (K Vial)
Figure 45. Australia Liposome Drug Delivery Sales and Growth Rate (2019-2030) & (K Vial)
Figure 46. LAMEA Liposome Drug Delivery Sales and Growth Rate (2019-2030) & (K Vial)
Figure 47. LAMEA Liposome Drug Delivery Sales Market Share by Country (2019-2030)
Figure 48. Mexico Liposome Drug Delivery Sales and Growth Rate (2019-2030) & (K Vial)
Figure 49. Brazil Liposome Drug Delivery Sales and Growth Rate (2019-2030) & (K Vial)
Figure 50. Turkey Liposome Drug Delivery Sales and Growth Rate (2019-2030) & (K Vial)
Figure 51. GCC Countries Liposome Drug Delivery Sales and Growth Rate (2019-2030) & (K Vial)
Figure 52. Global Liposome Drug Delivery Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 53. Global Liposome Drug Delivery Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 54. North America Liposome Drug Delivery Revenue (2019-2030) & (US$ Million)
Figure 55. North America Liposome Drug Delivery Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 56. Europe Liposome Drug Delivery Revenue (2019-2030) & (US$ Million)
Figure 57. Europe Liposome Drug Delivery Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 58. Asia-Pacific Liposome Drug Delivery Revenue (2019-2030) & (US$ Million)
Figure 59. Asia-Pacific Liposome Drug Delivery Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 60. LAMEA Liposome Drug Delivery Revenue (2019-2030) & (US$ Million)
Figure 61. LAMEA Liposome Drug Delivery Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 62. Liposome Drug Delivery Value Chain
Figure 63. Manufacturing Cost Structure
Figure 64. Liposome Drug Delivery Production Mode & Process
Figure 65. Direct Comparison with Distribution Share
Figure 66. Distributors Profiles
Figure 67. Years Considered
Figure 68. Research Process
Figure 69. Key Executives Interviewed
Figure 1. Liposome Drug Delivery Product Picture
Figure 2. Global Liposome Drug Delivery Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Liposome Drug Delivery Market Size (2019-2030) & (US$ Million)
Figure 4. Global Liposome Drug Delivery Sales (2019-2030) & (K Vial)
Figure 5. Global Liposome Drug Delivery Average Price (USD/Vial) & (2019-2030)
Figure 6. Global Top 5 and 10 Liposome Drug Delivery Players Market Share by Revenue in 2023
Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Liposomal Doxorubicin Picture
Figure 9. Liposomal Amphoteracin B Picture
Figure 10. Liposomal Paclitaxel Picture
Figure 11. Others Picture
Figure 12. Global Liposome Drug Delivery Sales by Type (2019 VS 2023 VS 2030) & (K Vial)
Figure 13. Global Liposome Drug Delivery Sales Market Share 2019 VS 2023 VS 2030
Figure 14. Global Liposome Drug Delivery Sales Market Share by Type (2019-2030)
Figure 15. Global Liposome Drug Delivery Revenue by Type (2019 VS 2023 VS 2030) & (K Vial)
Figure 16. Global Liposome Drug Delivery Revenue Market Share 2019 VS 2023 VS 2030
Figure 17. Global Liposome Drug Delivery Revenue Market Share by Type (2019-2030)
Figure 18. Fungal Infection Therapy Picture
Figure 19. Cancer & Tumor Therapy Picture
Figure 20. Others Picture
Figure 21. Global Liposome Drug Delivery Sales by Application (2019 VS 2023 VS 2030) & (K Vial)
Figure 22. Global Liposome Drug Delivery Sales Market Share 2019 VS 2023 VS 2030
Figure 23. Global Liposome Drug Delivery Sales Market Share by Application (2019-2030)
Figure 24. Global Liposome Drug Delivery Revenue by Application (2019 VS 2023 VS 2030) & (K Vial)
Figure 25. Global Liposome Drug Delivery Revenue Market Share 2019 VS 2023 VS 2030
Figure 26. Global Liposome Drug Delivery Revenue Market Share by Application (2019-2030)
Figure 27. North America Liposome Drug Delivery Sales and Growth Rate (2019-2030) & (K Vial)
Figure 28. North America Liposome Drug Delivery Sales Market Share by Country (2019-2030)
Figure 29. U.S. Liposome Drug Delivery Sales and Growth Rate (2019-2030) & (K Vial)
Figure 30. Canada Liposome Drug Delivery Sales and Growth Rate (2019-2030) & (K Vial)
Figure 31. Europe Liposome Drug Delivery Sales and Growth Rate (2019-2030) & (K Vial)
Figure 32. Europe Liposome Drug Delivery Sales Market Share by Country (2019-2030)
Figure 33. Germany Liposome Drug Delivery Sales and Growth Rate (2019-2030) & (K Vial)
Figure 34. France Liposome Drug Delivery Sales and Growth Rate (2019-2030) & (K Vial)
Figure 35. U.K. Liposome Drug Delivery Sales and Growth Rate (2019-2030) & (K Vial)
Figure 36. Italy Liposome Drug Delivery Sales and Growth Rate (2019-2030) & (K Vial)
Figure 37. Netherlands Liposome Drug Delivery Sales and Growth Rate (2019-2030) & (K Vial)
Figure 38. Asia Pacific Liposome Drug Delivery Sales and Growth Rate (2019-2030) & (K Vial)
Figure 39. Asia Pacific Liposome Drug Delivery Sales Market Share by Country (2019-2030)
Figure 40. China Liposome Drug Delivery Sales and Growth Rate (2019-2030) & (K Vial)
Figure 41. Japan Liposome Drug Delivery Sales and Growth Rate (2019-2030) & (K Vial)
Figure 42. South Korea Liposome Drug Delivery Sales and Growth Rate (2019-2030) & (K Vial)
Figure 43. Southeast Asia Liposome Drug Delivery Sales and Growth Rate (2019-2030) & (K Vial)
Figure 44. India Liposome Drug Delivery Sales and Growth Rate (2019-2030) & (K Vial)
Figure 45. Australia Liposome Drug Delivery Sales and Growth Rate (2019-2030) & (K Vial)
Figure 46. LAMEA Liposome Drug Delivery Sales and Growth Rate (2019-2030) & (K Vial)
Figure 47. LAMEA Liposome Drug Delivery Sales Market Share by Country (2019-2030)
Figure 48. Mexico Liposome Drug Delivery Sales and Growth Rate (2019-2030) & (K Vial)
Figure 49. Brazil Liposome Drug Delivery Sales and Growth Rate (2019-2030) & (K Vial)
Figure 50. Turkey Liposome Drug Delivery Sales and Growth Rate (2019-2030) & (K Vial)
Figure 51. GCC Countries Liposome Drug Delivery Sales and Growth Rate (2019-2030) & (K Vial)
Figure 52. Global Liposome Drug Delivery Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 53. Global Liposome Drug Delivery Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 54. North America Liposome Drug Delivery Revenue (2019-2030) & (US$ Million)
Figure 55. North America Liposome Drug Delivery Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 56. Europe Liposome Drug Delivery Revenue (2019-2030) & (US$ Million)
Figure 57. Europe Liposome Drug Delivery Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 58. Asia-Pacific Liposome Drug Delivery Revenue (2019-2030) & (US$ Million)
Figure 59. Asia-Pacific Liposome Drug Delivery Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 60. LAMEA Liposome Drug Delivery Revenue (2019-2030) & (US$ Million)
Figure 61. LAMEA Liposome Drug Delivery Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 62. Liposome Drug Delivery Value Chain
Figure 63. Manufacturing Cost Structure
Figure 64. Liposome Drug Delivery Production Mode & Process
Figure 65. Direct Comparison with Distribution Share
Figure 66. Distributors Profiles
Figure 67. Years Considered
Figure 68. Research Process
Figure 69. Key Executives Interviewed
